Related Experiment Video
Updated: Jun 5, 2026

Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos
Published on: March 21, 2021
Body composition modifications in patients under low protein diets
1Oakland University, William Beaumont School of Medicine, 3535 West Thirteen Mile Road, Rochester, MI 48073, USA. fdumler@beaumont.edu
Very low protein diets can maintain lean body mass in late-stage chronic kidney disease patients. However, close monitoring is crucial to prevent malnutrition due to illness or reduced intake.
Area of Science:
- Nephrology
- Nutritional Science
- Body Composition Analysis
Background:
- Chronic kidney disease (CKD) management often involves dietary modifications.
- Body composition changes are critical indicators of nutritional status in CKD patients.
Purpose of the Study:
- To review the impact of low protein diets on body composition in patients with chronic kidney disease (CKD).
- To evaluate body composition methods for clinical applicability in CKD.
Main Methods:
- Literature review of body composition techniques.
- Chronological appraisal of studies on low and very low protein diets in CKD stages III-V.
- Evaluation of nutritional status and body composition changes.
Main Results:
- Body composition methods were categorized by compartment, technique, and clinical utility.
- Very low protein diets demonstrated the ability to sustain lean and body cell mass in CKD stages III-V.
- Absence of CKD confounders was noted in one study on chronic undernutrition.
Conclusions:
- Very low protein diets can preserve lean body mass in advanced CKD.
- Malnutrition risk increases with intercurrent illness or reduced food intake.
- Regular clinical and nutritional monitoring by nephrologists and renal dietitians is essential.
Related Concept Videos
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Chronic Kidney Disease III: Interprofessional Care
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Nephrotic Syndrome I : Introduction
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution